{"date":"2025-08-14","count":30,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4198-2025-08-14-1949-13tdtzt","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"19:49:34","subject":"修正本公司114年第二季合併財務報告書","clause":"第53款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-08-14 19:49，「修正本公司114年第二季合併財務報告書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2025-08-14-1914-1djs54a","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"19:14:21","subject":"公告本公司訂定資本公積轉增資發行新股之除權基準日","clause":"第14款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2025-08-14 19:14，「公告本公司訂定資本公積轉增資發行新股之除權基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-08-14-1854-s83qt4","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"18:54:26","subject":"公告本公司114年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"第37款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-08-14 18:54，「公告本公司114年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-08-14-1854-1rxui7p","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"18:54:01","subject":"代子公司公告研發中新藥APC201用於治療膝蓋骨關節炎引起之局部疼痛一/二a期臨床試驗結果補充說明","clause":"第44款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-08-14 18:54，「代子公司公告研發中新藥APC201用於治療膝蓋骨關節炎引起之局部疼痛一/二a期臨床試驗結果補充說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-08-14-1848-1sm3lw","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"18:48:35","subject":"公告本公司114年現金增資股款催繳事宜","clause":"第44款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-08-14 18:48，「公告本公司114年現金增資股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2025-08-14-1828-vxh4e5","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"18:28:33","subject":"公告本公司處分有價證券","clause":"第20款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2025-08-14 18:28，「公告本公司處分有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-08-14-1801-69piyu","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"18:01:13","subject":"本公司將於114年08月21日召開上市前業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-08-14 18:01，「本公司將於114年08月21日召開上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-08-14-1748-vs4emg","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"17:48:55","subject":"公告本公司受邀參加Evercore中國生技峰會","clause":"第30款","fact_date":"2025-08-20","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-08-14 17:48，「公告本公司受邀參加Evercore中國生技峰會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-08-14-1741-1kbupvl","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"17:41:16","subject":"公告修正本公司113年度股東會年報部分內容","clause":"第51款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-08-14 17:41，「公告修正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-08-14-1735-198k64d","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"17:35:09","subject":"公告本公司114年第二季財務報告業經提報董事會。","clause":"第31款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-08-14 17:35，「公告本公司114年第二季財務報告業經提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-08-14-1734-9o00en","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"17:34:14","subject":"公告本公司法人董事改派法人代表人。","clause":"第6款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-08-14 17:34，「公告本公司法人董事改派法人代表人。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-08-14-1721-y5wss2","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"17:21:45","subject":"公告本公司自主開發的氟口比苯醯胺鹽類新藥，經審查取得歐洲發明專利","clause":"第44款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-08-14 17:21，「公告本公司自主開發的氟口比苯醯胺鹽類新藥，經審查取得歐洲發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-08-14-1712-1nrkjaf","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"17:12:36","subject":"本公司董事會通過114年第二季財務報告(更正公告主旨)","clause":"第43款","fact_date":"2025-08-11","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-08-14 17:12，「本公司董事會通過114年第二季財務報告(更正公告主旨)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-08-14-1647-ttnene","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"16:47:24","subject":"(更正公告)本公司114年上半年度財務報表已提報董事會","clause":"第43款","fact_date":"2025-08-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-08-14 16:47，「(更正公告)本公司114年上半年度財務報表已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-08-14-1638-105q0ri","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"16:38:37","subject":"公告本公司董事會通過民國114年第二季個別財務報告","clause":"第43款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-08-14 16:38，「公告本公司董事會通過民國114年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-08-14-1612-17nwc60","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"16:12:56","subject":"更正本公司114年第二季iXBRL報表之每股淨值","clause":"第44款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-08-14 16:12，「更正本公司114年第二季iXBRL報表之每股淨值」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-08-14-1610-sz6qfg","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"16:10:35","subject":"本公司中正路辦公室暨展示中心火災事件說明","clause":"第21款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-08-14 16:10，「本公司中正路辦公室暨展示中心火災事件說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-08-14-1607-7nuplr","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"16:07:00","subject":"代子公司(聲博科技)公告董事會決議解除財會主管競業禁止之限制","clause":"第21款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-08-14 16:07，「代子公司(聲博科技)公告董事會決議解除財會主管競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-08-14-1553-140kqs7","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"15:53:52","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第43款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-08-14 15:53，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-08-14-1538-167bzyx","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"15:38:49","subject":"更正說明13：數字誤植公告本公司114年第2季合併財務報告經董事會通過","clause":"第31款","fact_date":"2025-08-11","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-08-14 15:38，「更正說明13：數字誤植公告本公司114年第2季合併財務報告經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-08-14-1530-d1j5l0","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"15:30:20","subject":"代子公司Bio-Nutri co., ltd 依公開發行公司資金貸與及 背書保證處理準則第二十二條第一項第三款公告","clause":"第23款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-08-14 15:30，「代子公司Bio-Nutri co., ltd 依公開發行公司資金貸與及 背書保證處理準則第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-08-14-1530-fqtni8","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"15:30:14","subject":"更正本公司114年7月申報資金貸與資訊揭露明細表","clause":"第44款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-08-14 15:30，「更正本公司114年7月申報資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-08-14-1508-16u2prg","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-08-14","time":"15:08:53","subject":"代子公司公告「COMPOSITION AND METHOD FOR TREATINGA DRUG-RESISTANT CANCER用於治療抗藥性癌症的組合物和方法」取得日本發明專利","clause":"第44款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-08-14 15:08，「代子公司公告「COMPOSITION AND METHOD FOR TREATINGA DRUG-RESISTANT C」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-08-14-1502-7k4qh4","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"15:02:11","subject":"(更正114/06/30序號8重訊)公告本公司董事會通過財務主管暨會計主管異動","clause":"第8款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-08-14 15:02，「(更正114/06/30序號8重訊)公告本公司董事會通過財務主管暨會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-08-14-1453-1b9inhf","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"14:53:53","subject":"修正本公司113年度股東會年報部分內容","clause":"第51款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-08-14 14:53，「修正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-08-14-1450-7mi2k3","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"14:50:24","subject":"公告本公司受邀參加元富證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-08-14 14:50，「公告本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-08-14-1341-1ub20ox","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-08-14","time":"13:41:34","subject":"更正本公司114年第二季合併財務報告iXBRL申報資訊","clause":"第53款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-08-14 13:41，「更正本公司114年第二季合併財務報告iXBRL申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-08-14-1249-1kanrbb","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"12:49:21","subject":"依據證券交易所要求澄清媒體報導","clause":"第51款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-08-14 12:49，「依據證券交易所要求澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2025-08-14-1133-f5rb6p","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"11:33:18","subject":"本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2025-08-14 11:33，「本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-08-14-1005-xyhazt","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-08-14","time":"10:05:05","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-08-14 10:05，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}